Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 48
Filter
1.
J Clin Virol ; 97: 50-53, 2017 12.
Article in English | MEDLINE | ID: mdl-29107766

ABSTRACT

BACKGROUND: Bulk stool specimens are traditionally used for rotavirus detection but may be challenging to obtain from young children. Immediate and easy sampling may however be required in different situations, such as outbreak investigation. OBJECTIVES: We assessed the diagnostic performance of rectal swabs compared to bulk stools for the detection of rotavirus by Enzyme Immunoassay (EIA) and multiplex semi-nested reverse transcription PCR (semi-nested RT-PCR) in children recruited through active hospital-based surveillance of acute gastroenteritis in Norway. STUDY DESIGN: We obtained 265 paired bulk stool and rectal swab specimens from children under 5 years of age hospitalized with acute gastroenteritis (AGE). Both types of specimens were analyzed for rotavirus by EIA and semi-nested RT-PCR. In addition, VP6-spesific real-time PCR was used to evaluate the detection performance in the two specimen types. RESULTS: Concordant results were obtained in 257 (97%) paired specimens by EIA and in 248 (94%) pairs by semi-nested RT-PCR. Results of VP6-specific real-time PCR obtained from 100 pairs of specimens showed concordance in 91% of the pairs. Sensitivity and specificity for rectal swab specimens were 95% and 100% by EIA; 95% and 92% by semi-nested RT-PCR, respectively. CONCLUSION: Both EIA and semi-nested RT-PCR showed a high accuracy, and rectal swab specimens are appropriate for rotavirus diagnosis and may be used as an alternate specimen type when collection of bulk stool is not feasible.


Subject(s)
Feces/virology , Gastroenteritis/virology , Rectum/virology , Rotavirus Infections/diagnosis , Rotavirus/isolation & purification , Acute Disease/epidemiology , Child, Hospitalized , Child, Preschool , Data Accuracy , Disease Outbreaks/prevention & control , Female , Gastroenteritis/diagnosis , Gastroenteritis/epidemiology , Humans , Immunoenzyme Techniques/methods , Infant , Male , Norway/epidemiology , Real-Time Polymerase Chain Reaction/methods , Rotavirus/genetics , Rotavirus Infections/epidemiology , Sensitivity and Specificity , Serologic Tests , Specimen Handling
2.
J Clin Virol ; 94: 57-62, 2017 09.
Article in English | MEDLINE | ID: mdl-28759773

ABSTRACT

BACKGROUND: Around 40% of pregnant women in Norway are parvovirus B19 (B19V) seronegative and thus at risk for B19 V infection. Studies on samples from women with symptomatic disease or known exposure have shown that nucleic acid amplification assays combined with serology increase the sensitivity and improves the diagnostic procedure. OBJECTIVES: The aim was to investigate the seroprevalence of B19V infection, the occurrence of new infections and vertical transmission in a population-based pregnancy cohort, with special emphasis on the diagnostic methods. STUDY DESIGN: We randomly selected 1350 pregnant women from the Norwegian Mother and Child Cohort Study (MoBa), using an algorithm for the detection of B19V infection, including both serology and PCR. RESULTS: Maternal infection was confirmed in 50 subjects (3.7% of 1349 women), of which 35(70%) were viremic. Of the initially seronegative 33(6.8%) seroconverted. The estimated average annual seroconversion rate was 15.5%, with the highest estimated annual seroconversion rate of 31.6%. The rates of yearly seroconversion followed the pattern found in reports from Norwegian microbiology laboratories. Among all women, 31 (2.3%) had an inconclusive serological profile and 17 (54.8%) had detectable virus. Of the 16 women with virus detectable at gestational week 17-18, seven were still seronegative with absent seroconversion in the second sample taken at birth. All together 10 children were vertically infected. CONCLUSIONS: High incidence of viremic B19V infections and high estimated annual seroconversion rates were found. Lack of seroconversion despite longstanding viremia emphasizes the importance of including PCR when testing for B19V infection during pregnancy.


Subject(s)
Parvoviridae Infections/epidemiology , Parvovirus B19, Human/immunology , Adult , Algorithms , Antibodies, Viral/blood , Female , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Incidence , Norway/epidemiology , Parvoviridae Infections/immunology , Parvoviridae Infections/virology , Pregnancy , Seroepidemiologic Studies
3.
APMIS ; 125(8): 732-742, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28585306

ABSTRACT

Hantaviruses pose a public health concern worldwide causing haemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). Puumala virus (PUUV) is the most prevalent hantavirus in Central and Northern Europe, and causes a mild form of HFRS, also known as nephropathia epidemica (NE). In nature, the main host of PUUV is the bank vole (Myodes glareolus), and transmission to humans occurs through inhalation of aerosols from rodent excreta. Nephropathia epidemica is particularly prevalent in Nordic countries, however, few studies of PUUV have been performed in Norway. The aim of this study was to analyse the dynamics of PUUV in Norway and compare with bank vole population dynamics, and also to complement the current diagnostic methodology of NE in Norway. Our results showed a significant seasonal and geographical variation of NE, and a general parallel peak trend between bank vole population densities and human NE incidence. A real-time and a nested PCR were successfully established as an invaluable diagnostic tool, with detection and sequencing of PUUV in a human serum sample for the first time in Norway. Phylogenetic analysis showed clustering of the obtained human sample with previous Norwegian bank vole isolates.


Subject(s)
Arvicolinae/growth & development , Hantavirus Pulmonary Syndrome/epidemiology , Hantavirus Pulmonary Syndrome/virology , Hemorrhagic Fever with Renal Syndrome/epidemiology , Hemorrhagic Fever with Renal Syndrome/virology , Puumala virus/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Child , Child, Preschool , Cluster Analysis , Female , Hantavirus Pulmonary Syndrome/diagnosis , Hemorrhagic Fever with Renal Syndrome/diagnosis , Humans , Incidence , Infant , Infant, Newborn , Male , Middle Aged , Norway/epidemiology , Phylogeny , Polymerase Chain Reaction , Population Dynamics , Puumala virus/classification , Puumala virus/genetics , Real-Time Polymerase Chain Reaction , Seasons , Sequence Analysis, DNA , Sequence Homology , Serum/virology , Topography, Medical , Young Adult
4.
BMC Infect Dis ; 16: 254, 2016 06 07.
Article in English | MEDLINE | ID: mdl-27266273

ABSTRACT

BACKGROUND: Currently Norway does not recommend universal varicella vaccination for healthy children. This study assessed susceptibility to varicella-zoster virus (VZV) in the Norwegian population for the first time. METHODS: A national convenience sample of residual sera was tested for anti-VZV IgG by ELISA. We estimated age-specific seropositivity to VZV, controlling for sex and geographical distribution. We assessed differences between the proportions using the chi-square test and multivariable logistic regression. Seroprevalence data were compared to the varicella and herpes zoster-associated consultation rates in patients attending primary healthcare. RESULTS: Although 73.2 % (n = 1,540) of all samples were positive for VZV, only 11.2 % of samples collected from 1-year-olds were seropositive. There was a sharp increase in the proportion of seropositive in 3- and 5-year-olds (40.2 % and 65.4 %, respectively). By the school entry age of 6 years, 69.8 % of children were seropositive. The age-specific annual consultation rate for varicella in primary healthcare peaked in 1-year-olds, with 2,627 cases per 100,000 population. The profile of varicella-related consultations in primary healthcare mirrored the VZV seropositivity profile. The herpes zoster-related consultations in primary healthcare peaked in people over 70 years of age (702 cases per 100,000 population). CONCLUSIONS: VZV seroprevalence in Norway was somewhat lower than in some other European countries. The age-specific varicella-related consultation rates in primary healthcare mirrored the age profile of VZV seroprevalence.


Subject(s)
Chickenpox Vaccine/supply & distribution , Herpes Zoster/epidemiology , Herpesvirus 3, Human/immunology , Adolescent , Age Factors , Chi-Square Distribution , Chickenpox Vaccine/economics , Child , Child Health Services/statistics & numerical data , Child, Preschool , Disease Susceptibility , Female , Herpes Zoster/blood , Herpes Zoster/prevention & control , Humans , Infant , Logistic Models , Male , Norway/epidemiology , Primary Health Care/statistics & numerical data , Referral and Consultation/statistics & numerical data , Seroepidemiologic Studies , Vaccination
5.
Int J Pharm Pract ; 24(5): 349-57, 2016 Oct.
Article in English | MEDLINE | ID: mdl-26990579

ABSTRACT

OBJECTIVE: Many children who take medication require it during school time, and their participation in school activities could depend on it. The aim of this study was to identify whether schools have guidelines for medication management and to explore teachers' perceptions about medication administration practices and the characteristics affecting these practices using Bronfenbrenner's ecological systems theory as the framework. METHODS: A cross-sectional postal survey was conducted in Finland in 2010 covering a representative sample of comprehensive school teachers (n = 1700). The survey included sections on guidelines and practices for medication administration, beliefs about medicines, and background information on the respondent and the respondent's school. Quantitative and qualitative methods of analysis were used. KEY FINDINGS: The response rate was 56% (928/1664). At the national level (macrosystem), teachers reported uncertainty about existing laws and guidelines, while at the local level (exosystem), most of the teachers reported having medication management guidelines (73% primary; 76% lower secondary school). However, a majority described guidelines instructing them not to administer medicines to pupils. Medication management practices were found to differ depending on the province and size of school. At the personal level (microsystem), practices were also affected by teachers' experience of, and views about, medicines. CONCLUSION: No consistent medication administration guidelines exist in Finnish schools. Challenges were identified at all system levels of ecological theory. To ensure proper medication management, school staff need clear and consistent guidance developed in co-operation between different professions, and exploring ways to involve pharmacists in this task.


Subject(s)
Faculty/psychology , Health Knowledge, Attitudes, Practice , Medication Therapy Management , School Health Services , Cross-Sectional Studies , Female , Finland , Guidelines as Topic , Humans , Male
6.
Pediatr Infect Dis J ; 35(4): 396-400, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26974747

ABSTRACT

BACKGROUND: Norway introduced routine rotavirus immunization for all children born on or after September 1, 2014. We estimated the healthcare burden of all-cause gastroenteritis and rotavirus disease in children <5 years old to establish the prevaccine baseline and support the ongoing immunization program. METHODS: We examined national registry data on gastroenteritis-associated primary care consultations and hospitalizations for 2009-2013 and data on all deaths in children <5 years old reported during 2000-2013. We also established rotavirus hospital surveillance from February 2014 through January 2015. RESULTS: Before vaccine introduction, 114.5 cases per 1000 children <5 years old were treated in primary care and 11.8 children per 1000 were hospitalized with gastroenteritis annually. During hospital surveillance, rotavirus was detected in 65% (95% confidence interval: 60-70) of inpatient gastroenteritis cases. We estimated that 4.0 inpatient and 2.3 outpatient cases per 1000 children were seen in hospital with rotavirus disease annually, suggesting that 1 in 32 children was hospitalized by age 5. Additional 30.6 rotavirus cases per 1000 children consulted primary care annually or 1 in every 7 children by the age of 5 years. Rotavirus-associated mortality was estimated at 0.17 deaths per 100,000 children <5 years old, corresponding to 1 death every second year. CONCLUSIONS: Rotavirus remains the primary cause of severe gastroenteritis in children in Norway. The unique population-based registers, in combination with an established rotavirus surveillance platform, provide a well-suited setting to evaluate the impact of rotavirus vaccination.


Subject(s)
Cost of Illness , Rotavirus Infections/epidemiology , Rotavirus , Child, Preschool , Female , Humans , Immunization Programs , Infant , Male , Mortality , Norway/epidemiology , Primary Health Care , Public Health Surveillance , Referral and Consultation , Registries , Rotavirus Infections/prevention & control , Rotavirus Vaccines , Sentinel Surveillance , Vaccination
7.
J Infect Dis ; 213(6): 930-3, 2016 Mar 15.
Article in English | MEDLINE | ID: mdl-26563239

ABSTRACT

The live attenuated vesicular stomatitis virus-vectored Ebola vaccine rVSV-ZEBOV is currently undergoing clinical trials in West Africa. The vaccine is to be stored at -70°C or less. Since maintaining the cold chain is challenging in rural areas, the rVSV-ZEBOV vaccine's short-term and long-term stability at different temperatures was examined. Different dilutions were tested since the optimal vaccine dosage had not yet been determined at the start of this experiment. The results demonstrate that the original vaccine formulation was stable for 1 week at 4°C and for 24 hours at 25°C. The stability of the vaccine was compromised by both high temperatures and dilution.


Subject(s)
Ebola Vaccines/chemistry , Vaccine Potency , Animals , Chlorocebus aethiops , Hydrogen-Ion Concentration , Temperature , Time Factors , Vero Cells
8.
Pharmacy (Basel) ; 4(4)2016 Oct 13.
Article in English | MEDLINE | ID: mdl-28970402

ABSTRACT

With increased development of medical technology (MT), new challenges emerge related to education and training of pharmacists and other healthcare specialists. Currently, only a few universities in the EU promote MT education and research. OBJECTIVES: The aim of this study was to evaluate the current status, views on, and need for the education on MT for the pharmacy students and practicing pharmacists in the Baltic and Nordic countries. METHODS: The representatives of higher education institutions and community/hospital pharmacists from six Baltic and Nordic countries participated in a qualitative cross-sectional exploratory internet-based study from May to October 2014. RESULTS: Approximately two-third of the respondents considered professional knowledge about MT products important for pharmacists, but half of them had never participated in any MT courses. More practicing pharmacists than representatives of academia underlined the need for increased MT education for pharmacy students in the future. CONCLUSIONS: The pharmacists in the Baltic and Nordic countries consider the professional knowledge about MT as pertinent in their education and work. The limited number and status of MT courses available today, however, is a major concern among both pharmacy students and practicing pharmacists in these countries. In the future, increasing education combining theory and practice about MT products would be one possible solution to overcome this challenge.

9.
APMIS ; 123(9): 759-64, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26126504

ABSTRACT

Tick-borne encephalitis (TBE) is the most important viral tick-borne disease in Europe and can cause severe disease in humans. In Norway, human cases have been reported only from the southern coast. The aim of this study was to investigate the prevalence of tick-borne encephalitis virus (TBEV) in questing Ixodes ricinus ticks from the north-western part of Norway. A total of 4509 ticks were collected by flagging in May and June 2014. A subpopulation of 2220 nymphs and 162 adult ticks were analysed by real-time PCR and positive samples were confirmed by pyrosequencing. The estimated prevalence of TBEV was 3.08% among adult ticks from Sekken in Møre og Romsdal County and 0.41% among nymphs from both Hitra and Frøya in Sør-Trøndelag County. This study indicates that TBEV might be more widespread than the distribution of reported human cases suggests.


Subject(s)
Encephalitis Viruses, Tick-Borne/isolation & purification , Encephalitis, Tick-Borne/epidemiology , Ixodes/virology , Ticks/virology , Animals , Humans , Islands , Norway/epidemiology , Prevalence
10.
Front Public Health ; 3: 54, 2015.
Article in English | MEDLINE | ID: mdl-25874194

ABSTRACT

BACKGROUND: In Europe, the most prevalent hantavirus, Puumala virus, is transmitted by bank voles and causes nephropathia epidemica in human. The European spatial distribution of nephropathia epidemica is investigated here for the first time with a rich set of environmental variables. METHODS: The influence of variables at the landscape and regional level is studied through multilevel logistic regression, and further information on their effects across the different European ecoregions is obtained by comparing an overall niche model (boosted regression trees) with regressions by ecoregion. RESULTS: The presence of nephropathia epidemica is likely in populated regions with well-connected forests, more intense vegetation activity, low soil water content, mild summers, and cold winters. In these regions, landscapes with a higher proportion of built-up areas in forest ecotones and lower minimum temperature in winter are expected to be more at risk. Climate and forest connectivity have a stronger effect at the regional level. If variables are staying at their current values, the models predict that nephropathia epidemica may know intensification but should not spread (although southern Sweden, the Norwegian coast, and the Netherlands should be kept under watch). CONCLUSION: Models indicate that large-scale modeling can lead to a very high predictive power. At large scale, the effect of one variable on disease may follow three response scenarios: the effect may be the same across the entire study area, the effect can change according to the variable value, and the effect can change depending on local specificities. Each of these scenarios impacts large-scale modeling differently.

11.
Ticks Tick Borne Dis ; 6(3): 356-63, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25838177

ABSTRACT

The article presents the results of the first study on seasonal activity of ticks and prevalence of tick-borne encephalitis virus (TBEV) in nymphs from the Silesian Province (Southern Poland). Previous studies on the prevalence of TBEV in ticks in Poland have been conducted mostly in northern and eastern regions, but none in the Silesian Province itself. The aims of this study were to analyse the seasonal variation in tick populations and compare TBEV prevalence in nymphs from different geographical locations in the Silesia. A total of 5160 questing Ixodes ricinus ticks were collected by the flagging method from 23 localities in southern Poland in 2010. Micro-climatic parameters (air temperature and humidity) were measured in order to estimate their influence on tick population. The highest tick activity was recorded in spring and was positively correlated with relative air humidity (RH). TBEV in the Silesian Province was analysed in 1750 nymphs and an overall prevalence was 0.11% (2 pools out of 175 analysed). The results of this study show that TBEV pool prevalence in nymphs is low in accordance with the low number of TBE cases reported within the region.


Subject(s)
Arachnid Vectors/virology , Encephalitis Viruses, Tick-Borne/physiology , Encephalitis, Tick-Borne/epidemiology , Ixodidae/virology , Animals , Climate , Encephalitis Viruses, Tick-Borne/genetics , Encephalitis, Tick-Borne/virology , Female , Humans , Ixodes/virology , Male , Nymph , Poland/epidemiology , Prevalence , Risk , Seasons
12.
APMIS ; 123(4): 321-5, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25628065

ABSTRACT

Infection by Toxoplasma gondii may lead to complications in the foetus if the mother suffers from primary infection during pregnancy. Previously infected women have produced toxoplasma-specific IgG antibodies. The most recent study on prevalence of toxoplasma IgG in the Norwegian pregnant population was conducted 20 years ago. The present study is part of a research programme initiated by the Norwegian Institute of Public Health. We aimed to update the knowledge regarding the prevalence of toxoplasma IgG among pregnant women in Norway. In this cross-sectional study, sera from 1922 pregnant women in Buskerud (992) and Sør-Trøndelag counties (930) in Norway were collected consecutively. The presence of toxoplasma IgG was identified by values ≥8 IU/mL using an ELISA test. The overall prevalence of toxoplasma IgG seropositivity was 9.3% (95% CI 8.1-10.7); Sør-Trøndelag 10.4% (95% CI 8.6-12.6) and Buskerud 8.3% (95% CI 6.7-10.2). There was no difference between the counties (p = 0.13), and the result did not differ from prevalences found in 1974 (12.1%) and 1994 (10.7%). We found a higher prevalence among women ≥40 years (OR 2.65, 95% CI 1.30-5.42). The prevalence of toxoplasma IgG among pregnant women in Norway is low and has been stable during the last decades.


Subject(s)
Antibodies, Protozoan/blood , Immunoglobulin G/blood , Pregnancy Complications, Parasitic/epidemiology , Pregnancy Complications, Parasitic/immunology , Toxoplasmosis/epidemiology , Adult , Cross-Sectional Studies , Female , Humans , Immunoglobulin G/immunology , Norway/epidemiology , Pregnancy , Risk Factors , Seroepidemiologic Studies , Toxoplasma/immunology
13.
Infect Dis (Lond) ; 47(1): 52-6, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25342575

ABSTRACT

The aim of this study was to assess the seroprevalence of antibodies to tick-borne encephalitis virus (TBEV) and Anaplasma phagocytophilum in a healthy adult population from Sogn and Fjordane county in western Norway. Sera from 1, 213 blood donors were analysed for IgG-antibodies to TBEV, and a random subgroup of 301 donors for IgG to A. phagocytophilum. In the TBEV ELISA, five (0.4%) sera were positive. These were all interpreted as "false" positives, as four had received vaccines against flaviviruses, and the remaining was negative for neutralizing antibodies to TBEV. Antibodies to A. phagocytophilum were detected by indirect immunofluorescence in 49 (16.2%) subjects (titer range 80-1280). The results indicate that TBE currently is not endemic in this part of western Norway. However, there is serological evidence of the existence of human granulocytic anaplasmosis in the population.


Subject(s)
Anaplasma phagocytophilum/immunology , Antibodies, Bacterial/blood , Antibodies, Viral/blood , Ehrlichiosis/epidemiology , Encephalitis Viruses, Tick-Borne/immunology , Encephalitis, Tick-Borne/epidemiology , Adult , Aged , Blood Donors , Ehrlichiosis/blood , Ehrlichiosis/immunology , Encephalitis, Tick-Borne/blood , Encephalitis, Tick-Borne/immunology , Endemic Diseases , Female , Humans , Immunoglobulin G/blood , Male , Middle Aged , Norway/epidemiology , Seroepidemiologic Studies , Young Adult
14.
Influenza Other Respir Viruses ; 9(2): 59-63, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25534826

ABSTRACT

OBJECTIVES: An unexpectedly high proportion of children were admitted for severe respiratory infections at the Oslo University Hospital, Ullevål, Norway, during September and October, 2014. In light of the ongoing outbreak of enterovirus-D68 (EV-D68) in North America a real-time RT-PCR for screening of enterovirus and enterovirus D68 was established. DESIGN: We developed a duplex real-time RT-PCR for rapid screening of enterovirus D68. The method target the 5' non-translated region (NTR) of the HEV genome at a location generally used for enterovirus detection. SAMPLE: Nasopharyngeal samples (n = 354), from children <15 years of age, received for respiratory virus analysis in OUH during September 1st and October 31nd, 2014, were tested for enterovirus and screened for enterovirus D68. MAIN OUTCOME MEASURES AND RESULTS: The duplex real-time RT-PCR method was an efficient tool for rapid screening for EV-D68 in respiratory specimens. Enterovirus was detected in 66 (22%) of 303 pediatric nasopharyngeal samples collected from children hospitalised with acute respiratory infection within the two-month period. Out of these, 33 (50%) were EV-D68. EV-D68 was associated with acute flaccid paralysis in one child. CONCLUSIONS: An unexpectedly high proportion of children admitted for severe respiratory infections at the Oslo University Hospital, Ullevål, Norway, were diagnosed with EV- D68 during September 1st and October 31nd, 2014. These results emphasise that greater vigilance is required throughout Europe as enteroviruses are cause of severe respiratory disease.


Subject(s)
Enterovirus D, Human/isolation & purification , Enterovirus Infections/epidemiology , Respiratory Tract Infections/diagnosis , Respiratory Tract Infections/epidemiology , Adolescent , Child , Child, Preschool , Disease Outbreaks , Enterovirus Infections/diagnosis , Enterovirus Infections/virology , Europe , Hospitalization , Humans , Infant , Infant, Newborn , Norway/epidemiology , Paralysis , Real-Time Polymerase Chain Reaction , Respiratory Tract Infections/virology , Seasons , Young Adult
15.
Res Social Adm Pharm ; 11(2): 297-302, 2015.
Article in English | MEDLINE | ID: mdl-25096599

ABSTRACT

BACKGROUND: Women frequently experience health problems and use medicines during pregnancy, and thus need information about their medicines. Knowledge about factors associated with medicine information needs is important for pharmacists when tailoring medication counseling for these pregnant women. OBJECTIVES: The aim was to investigate how socioeconomic factors, health literacy, health status, and use of medicines are associated with the need for drug information among pregnant women. METHODS: A cross-sectional internet-based survey was posted using the Questback program (www.questback.com) on 1-4 websites commonly used by pregnant women in the participating countries within the Americas, Europe, and Australia. Multivariate logistic regression analysis was used. Logistic regression analysis was used for multivariate analysis when measuring the association of maternal socio-demographics and health-related characteristics with the need for medicines information. RESULTS: A higher need for medicines information was associated with primiparity (OR 1.56, CI 1.40-1.75), age of 35+ years (OR 1.26, CI 1.03-1.54), university education (OR 1.33, CI 1.17-1.51), low health literacy (OR 1.96, CI 1.50-2.55), use of medication for chronic diseases (OR 2.67, CI 2.28-3.13), use of medication for acute illnesses (OR 1.88, CI 1.64-2.15), use of OTCs (2+ OTC medicines, OR 1.87, CI 1.60-2.20), use of herbal preparations (OR 1.57, CI 1.37-1.80), and region of residence in Eastern Europe (OR 2.36, CI 2.00-2.79) and Northern Europe (OR 1.26, CI 1.10-1.44). CONCLUSIONS: The need for medicines information among pregnant women increases with the number of health problems and use of both prescription and OTC medicines as well as herbal preparations. Women with lower health literacy express a higher need for medicines information. These groups are primary targets for intensified counseling.


Subject(s)
Health Knowledge, Attitudes, Practice , Health Literacy/statistics & numerical data , Health Services Needs and Demand/statistics & numerical data , Patient Education as Topic , Adult , Cross-Sectional Studies , Data Collection , Female , Health Status , Humans , Internet , Logistic Models , Multivariate Analysis , Nonprescription Drugs/administration & dosage , Pregnancy , Prescription Drugs/administration & dosage , Socioeconomic Factors , Young Adult
16.
Ticks Tick Borne Dis ; 5(6): 663-7, 2014 Oct.
Article in English | MEDLINE | ID: mdl-25108791

ABSTRACT

The knowledge of the exact distribution of tick-borne encephalitis virus (TBEV) endemic foci is crucial to plan and implement the optimal prevention of tick-borne encephalitis (TBE), including a vaccination program. In Poland, however, there is still no data on the local distribution of TBEV in many areas of the country. Silesian agglomeration area (Southern Poland) is a highly urbanized and industrialized region of the country, where TBE cases are only sporadically recorded. In this study, a total of 4350 adult Ixodes ricinus were collected between September 2010 and June 2012 at twelve locations. The screening using real-time PCR was carried out on 854 tick pools of five specimens, and the positive pools were verified by pyrosequencing. TBEV was identified in 13 pools (1.52%) at 4 sites, of which 9 pools were verified by pyrosequencing. An overall pool prevalence was estimated at 0.31% ranging from 0.19% to 1.11% for positive locations [95% CI 0.16-0.52], which is comparable with regions with high number of TBE cases reported annually.


Subject(s)
Arachnid Vectors/virology , Encephalitis Viruses, Tick-Borne/isolation & purification , Encephalitis, Tick-Borne/virology , Ixodes/virology , Animals , Encephalitis Viruses, Tick-Borne/genetics , Encephalitis, Tick-Borne/epidemiology , Female , Humans , Male , Poland/epidemiology , Prevalence
17.
Vaccine ; 32 Suppl 1: A134-9, 2014 Aug 11.
Article in English | MEDLINE | ID: mdl-25091668

ABSTRACT

Interference from transplacental and breast milk antibodies may impede the performance of oral live vaccines. The effect of breastfeeding on the immunogenicity of Rotarix, a two-dose oral monovalent rotavirus vaccine, was examined in a community-based trial in New Delhi, India. Four hundred mother-infant pairs were randomized into two equal groups. Infants were aged 6-7 weeks at enrollment. Mothers were encouraged to either breastfeed or to withhold breastfeeding during the 30 min prior to and after each vaccine dose was administered. We collected blood specimens from infants at enrollment and 4 weeks after the second vaccine dose. Blood and breast milk specimens were obtained from mothers at baseline and breast milk specimens were collected at the time of the second vaccine dose. Seroconversion was defined as infant serum anti-VP6 IgA antibody level of ≥20 IU/mL 4 weeks after the second vaccine dose and a ≥4-fold rise from baseline. There was no difference in the proportion who seroconverted between the two groups (26% vs 27%; p=0.92). The levels of infant serum IgA, maternal serum and breast milk IgA and IgG anti-rotavirus antibodies predicted the anti-rotavirus IgA level in infants at end-study and explained approximately 10% of the variability of the immune response (r(2)=0.10, p<0.001). In this population, the immune response to Rotarix was not enhanced by withholding breastfeeding around the time of vaccination. Maternal anti-rotavirus antibodies explained little of the variability in the immune response to the vaccine. Factors other than maternal anti-rotavirus antibodies probably explain why infants in low-and middle-income settings respond poorly to live oral rotavirus vaccines.


Subject(s)
Antibody Formation , Breast Feeding , Rotavirus Infections/prevention & control , Rotavirus Vaccines/immunology , Vaccine Potency , Adult , Antibodies, Viral/blood , Antibodies, Viral/chemistry , Female , Humans , Immunity, Maternally-Acquired , Immunoglobulin A/blood , Immunoglobulin A/chemistry , Immunoglobulin G/blood , Immunoglobulin G/chemistry , India , Infant , Male , Milk, Human/chemistry , Milk, Human/immunology , Vaccines, Attenuated/immunology , Young Adult
18.
Infect Genet Evol ; 26: 340-7, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24960396

ABSTRACT

This study investigated and reports norovirus diarrhoea, genetic diversity and associated clinical symptoms, HIV status and seasonality in a paediatric population of Tanzania. Stool specimens and demographic/clinical information, were prospectively collected from 705 hospitalised children with diarrhoea (cases) and 561 children without diarrhoea (controls) between 2010 and 2011. Norovirus detection was done by real-time RT-PCR. Genotype was determined using Gel-based and real time RT-PCR methods and sequencing targeting the polymerase and the capsid region respectively. Norovirus was detected in 14.3%, 181/1266 children. The prevalence of norovirus was significantly higher in cases (18.3%, 129/705) than in controls, (9.2%, 52/561), P<0.05. Except for one child who had double infection with GI and GII all 129 cases had GII. Among controls, 23.1% had GI and 76.9% had GII. Norovirus GII.4 was significantly more prevalent in cases 87.9% than in controls 56.5%. Other genotypes detected in both cases and controls were GII.21, GII.16 and GII.g. The highest numbers of norovirus were detected in April 2011. The number of norovirus detected was significantly higher during the first than second year of life (109/540, 20.2% vs. 20/165, 12.1%). The prevalence of norovirus in HIV-positive and negative children was (21.2%, 7/33) and (10.3%, 40/390, P=0.05) respectively, regardless of diarrhoea symptoms. No significant difference in gender, parent's level of education or nutritional status with norovirus infection was observed within cases or controls. This study confirms the significant role of norovirus infection, especially GII.4 in diarrhoeic children who need hospitalisation and adds knowledge on norovirus epidemiology in the African region.


Subject(s)
Caliciviridae Infections/virology , Diarrhea/epidemiology , Gastroenteritis/virology , Genetic Variation , Hospitalization , Norovirus/genetics , Adolescent , Age Distribution , Caliciviridae Infections/complications , Case-Control Studies , Child , Child, Preschool , Diarrhea/etiology , Female , Gastroenteritis/complications , Genotype , Humans , Infant , Infant, Newborn , Male , Molecular Sequence Data , Norovirus/classification , Phylogeny , Prevalence , Prospective Studies , Seasons , Tanzania/epidemiology , Young Adult
19.
PLoS One ; 9(5): e97562, 2014.
Article in English | MEDLINE | ID: mdl-24844631

ABSTRACT

BACKGROUND: Tanzania currently rolls out vaccination against rotavirus-diarrhea, a major cause of child illness and death. As the vaccine covers a limited number of rotavirus variants, this study describes the molecular epidemiology of rotavirus among children under two years in Dar es Salaam, Tanzania, prior to implementation of vaccination. METHODS: Stool specimens, demographic and clinical information, were collected from 690 children admitted to hospital due to diarrhea (cases) and 545 children without diarrhea (controls) during one year. Controls were inpatient or children attending child health clinics. Rotavirus antigen was detected using ELISA and positive samples were typed by multiplex semi-nested PCR and sequencing. RESULTS: The prevalence of rotavirus was higher in cases (32.5%) than in controls (7.7%, P<0.001). The most common G genotypes were G1 followed by G8, G12, and G4 in cases and G1, G12 and G8 in controls. The Tanzanian G1 variants displayed 94% similarity with the Rotarix vaccine G1 variant. The commonest P genotypes were P[8], P[4] and P[6], and the commonest G/P combination G1 P[8] (n = 123), G8 P[4] and G12 P[6]. Overall, rotavirus prevalence was higher in cool (23.9%) than hot months (17.1%) of the year (P = 0.012). We also observed significant seasonal variation of G genotypes. Rotavirus was most frequently found in the age group of four to six months. The prevalence of rotavirus in cases was lower in stunted children (28.9%) than in non-stunted children (40.1%, P = 0.003) and lower in HIV-infected (15.4%, 4/26) than in HIV-uninfected children (55.3%, 42/76, P<0.001). CONCLUSION: This pre-vaccination study shows predominance of genotype G1 in Tanzania, which is phylogenetically distantly related to the vaccine strains. We confirm the emergence of genotype G8 and G12. Rotavirus infection and circulating genotypes showed seasonal variation. This study also suggests that rotavirus may not be an opportunistic pathogen in children infected with HIV.


Subject(s)
Genotype , Rotavirus Infections/genetics , Rotavirus Vaccines/administration & dosage , Rotavirus , Vaccination , Child, Preschool , Female , HIV Infections/epidemiology , HIV Infections/genetics , HIV Infections/virology , Humans , Infant , Infant, Newborn , Male , Rotavirus/genetics , Rotavirus/isolation & purification , Rotavirus Infections/epidemiology , Rotavirus Infections/prevention & control , Tanzania/epidemiology
20.
J Med Internet Res ; 16(2): e60, 2014 Feb 20.
Article in English | MEDLINE | ID: mdl-24565696

ABSTRACT

BACKGROUND: A wide variety of information sources on medicines is available for pregnant women. When using multiple information sources, there is the risk that information will vary or even conflict. OBJECTIVE: The objective of this multinational study was to analyze the extent to which pregnant women use multiple information sources and the consequences of conflicting information, and to investigate which maternal sociodemographic, lifestyle, and medical factors were associated with these objectives. METHODS: An anonymous Internet-based questionnaire was made accessible during a period of 2 months, on 1 to 4 Internet websites used by pregnant women in 5 regions (Eastern Europe, Western Europe, Northern Europe, Americas, Australia). A total of 7092 responses were obtained (n=5090 pregnant women; n=2002 women with a child younger than 25 weeks). Descriptive statistics and logistic regression analysis were used. RESULTS: Of the respondents who stated that they needed information, 16.16% (655/4054) used one information source and 83.69% (3393/4054) used multiple information sources. Of respondents who used more than one information source, 22.62% (759/3355) stated that the information was conflicted. According to multivariate logistic regression analysis, factors significantly associated with experiencing conflict in medicine information included being a mother (OR 1.32, 95% CI 1.11-1.58), having university (OR 1.33, 95% CI 1.09-1.63) or other education (OR 1.49, 95% CI 1.09-2.03), residing in Eastern Europe (OR 1.52, 95% CI 1.22-1.89) or Australia (OR 2.28, 95% CI 1.42-3.67), use of 3 (OR 1.29, 95% CI 1.04-1.60) or >4 information sources (OR 1.82, 95% CI 1.49-2.23), and having ≥2 chronic diseases (OR 1.49, 95% CI 1.18-1.89). Because of conflicting information, 43.61% (331/759) decided not to use medication during pregnancy, 30.30% (230/759) sought a new information source, 32.67% (248/759) chose to rely on one source and ignore the conflicting one, 25.03% (190/759) became anxious, and 2.64% (20/759) did nothing. Factors significantly associated with not using medication as a consequence of conflicting information were being pregnant (OR 1.75, 95% CI 1.28-2.41) or experiencing 3-4 health disorders (OR 1.99, 95% CI 1.10-3.58). Women with no chronic diseases were more likely not to take medicines than women with ≥2 chronic diseases (OR 2.22, 95% CI 1.47-3.45). Factors significantly associated with becoming anxious were >4 information sources (OR 2.67, 95% CI 1.70-4.18) and residing in Eastern Europe (OR 0.57, 95% CI 0.36-0.90). CONCLUSIONS: Almost all the pregnant women used multiple information sources when seeking information on taking medicines during pregnancy and one-fifth obtained conflicting information, leading to anxiety and the decision not to use the medication. Regional, educational, and chronic disease characteristics were associated with experiencing conflicting information and influenced the decision not to use medication or increased anxiety. Accurate and uniform teratology information should be made more available to the public.


Subject(s)
Consumer Health Information/statistics & numerical data , Drug Therapy , Health Personnel/statistics & numerical data , Information Seeking Behavior , Internet/statistics & numerical data , Pregnancy , Americas , Australia , Data Collection , Europe , Family , Female , Friends , Humans , Information Services/statistics & numerical data , Logistic Models , Socioeconomic Factors , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...